-
Cognizant, Gilead Sciences extend partnership for genAI
31 Jan 2025 20:58 GMT
… existing relationship with biopharmaceutical company Gilead Sciences to deliver better cost leadership … IT systems.Â
Earlier this month, Gilead Sciences and LEO Pharma announced a …
-
Breaking Down Gilead Sciences: 22 Analysts Share Their Views
29 Jan 2025 15:24 GMT
… how financial experts perceive Gilead Sciences. The following summary outlines … on Gilead Sciences analyst ratings.
Unveiling the Story Behind Gilead Sciences
Gilead Sciences develops … from Immunomedics).
Key Indicators: Gilead Sciences's Financial Health
…
-
Cell Therapy Regenerative Medicine Market Expected to Flourish at 15.78% CAGR to 170.0 Billion USD | Gilead Sciences
29 Jan 2025 02:00 GMT
… Co.
Poseidonn
Intellia Therapeutics
Pfizer
Gilead Sciences
Johnson Johnson
CRISPR Therapeutics
Amgen …
-
From Underperformance to Opportunity Biotechs Case for 2025
01 Feb 2025 16:16 GMT
… and acquisitions have periodically occurred. Gilead Sciences, for example, made headlines with … ;news-details/2024/gilead-sciences-announces-completion-of-acquisition-of …
-
Biotech Market to Grow by USD 805.6 Billion (2025-2029), Boosted by Vendor Innovation, with AI Driving Market Transformation - Technavio
01 Feb 2025 03:07 GMT
… La Roche Ltd., Genmab AS, Gilead Sciences Inc., Johnson and Johnson Inc … La Roche Ltd., Genmab AS, Gilead Sciences Inc., Johnson and Johnson Inc …
-
Organ Transplantation Immunosuppressive Drug Market Growth Maintained at 4.6% CAGR to Reach 37.3 Billion USD by 2032
01 Feb 2025 02:00 GMT
… Include:
Astellas
Pfizer
Novartis
Sanofi
Gilead Sciences
Takeda Pharmaceutical Company
HoffmannLa Roche …
-
Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts
31 Jan 2025 21:53 GMT
… Merck & Company, Inc. MRK, Gilead Sciences, Inc. GILD and Bristol-Myers … exposure, including AbbVie Inc. ABBV, Gilead Sciences, and Eli Lilly and Company …
-
CAR T-cell therapy reaches a turning point: Are we on the brink of first-line use?
31 Jan 2025 20:21 GMT
… the CAR T therapy opportunity. Gilead Sciences bought Kite Pharma in October …
-
Top 20 biopharma companies’ market caps rise 1.7% over 2024 amid policy
31 Jan 2025 14:58 GMT
… growth on a reported basis.
Gilead Sciences achieved a 14% increase in …
-
Ulcerative Colitis Market Set for Major Expansion by 2034, Reports DelveInsight
31 Jan 2025 13:56 GMT
… , Pfizer, EA Pharma, Kissei Pharma, Gilead Sciences, Galapagos NV, Celgene (Bristol-Myers … , Pfizer, EA Pharma, Kissei Pharma, Gilead Sciences, Galapagos NV, Celgene (Bristol-Myers …
About
© 1995-2025